Pgp (P-glycoprotein or ABCB1) is present in normal tissues, such as the liver, kidney, gastrointestinal tract, and blood–brain barrier; therefore, reversing multidrug resistance via blockade of Pgp holds a great challenge; therefore, cancer-selective approaches are principally expected. Here, PGP is linked to cancer.